Oruka Therapeutics (ORKA) Research & Development (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly Research & Development came in at $130000.0 in Q2 2024, down 48.82% year-on-year from $254000.0 in Q3 2023, and down 21.21% quarter-over-quarter from $165000.0 in Q1 2024.
Oruka Therapeutics (ORKA) Research & Development (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Research & Development history runs 15 years deep, the most recent figure standing at $130000.0 for Q2 2024.
- On a quarterly basis, Research & Development fell 48.82% year-over-year to $130000.0 in Q2 2024; TTM through Jun 2024 was $664000.0, a 61.6% decrease from a year earlier, with the FY2023 full-year figure at $1.0 million, down 78.67% from the prior year.
- Research & Development retreated to $130000.0 in Q2 2024 per ORKA's latest filing, from $165000.0 in the prior quarter.
- Across five years, Research & Development topped out at $3.9 million in Q4 2021 and bottomed at $47000.0 in Q4 2023.
- The 5-year median for Research & Development is $707000.0 (2022), against an average of $1.4 million.
- Across the five-year window, Research & Development jumped 861.56% in 2021 and plunged 98.45% in 2022, its largest moves.
- Year by year, Research & Development stood at $3.2 million in 2020, then advanced by 23.0% to $3.9 million in 2021, then plunged by 98.45% to $61000.0 in 2022, then fell by 22.95% to $47000.0 in 2023, then surged by 176.6% to $130000.0 in 2024.
- Per Business Quant, the three latest ORKA Research & Development figures stand at $130000.0 (Q2 2024), $165000.0 (Q1 2024), and $47000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 322,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 390,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.44 Mn |
| Jun 30, 2021 | 3.58 Mn |
| Mar 31, 2021 | 2.88 Mn |
| Dec 31, 2020 | 3.20 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | 372,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 384,000.00 |
| Sep 30, 2019 | 347,000.00 |